Science Explorer Back to mapMap

Most cited papers from Shenzhen Third People’s Hospital

What are the most cited papers from Shenzhen Third People’s Hospital?

The most cited paper from Shenzhen Third People’s Hospital is "Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis" (Wei-Jie Guan et al., 2020), with 3,777 citations. Next come "Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2" (3,197) and "Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses" (3,127).

Showing 50 of 59 papers. Every paper with more than 303 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis Wei-Jie Guan et al. · European Respiratory Journal Open access 26 Mar 2020 3,777
2 Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 Qihui Wang, Yanfang Zhang, Lili Wu et al. · Cell Open access 9 Apr 2020 3,197
3 Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses Shuo Su, Gary Wong, Weifeng Shi et al. · Trends in Microbiology ReviewOpen access 21 Mar 2016 3,127
4 Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 Mingfeng Liao, Yang Liu, Jing Yuan et al. · Nature Medicine Open access 12 May 2020 2,780
5 Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019 Juanjuan Zhao et al. · Clinical Infectious Diseases Open access 27 Mar 2020 2,676
6 Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma Chenguang Shen et al. · JAMA Open access 27 Mar 2020 2,425
7 Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Yingxia Liu et al. · Science China Life Sciences Open access 9 Feb 2020 2,161
8 Human neutralizing antibodies elicited by SARS-CoV-2 infection Bin Ju et al. · Nature Open access 26 May 2020 1,835
9 Clinical characteristics of 2019 novel coronavirus infection in China Wei‐jie Guan et al. · medRxiv PreprintOpen access 9 Feb 2020 1,486
10 A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 Yan Wu et al. · Science Open access 13 May 2020 1,109
11 COVID-19: Abnormal liver function tests Qingxian Cai, Deliang Huang, Hong Yu et al. · Journal of Hepatology Open access 13 Apr 2020 1,086
12 Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis Jie Li et al. · ˜The œLancet. Gastroenterology & hepatology Review 19 Mar 2019 1,067
13 Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients Zhuo Long Zhou et al. · Cell Host & Microbe Open access 4 May 2020 1,046
14 COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas Xianwen Ren et al. · Cell Open access 4 Feb 2021 950
15 Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 Aymeric Silvin et al. · Cell Open access 5 Aug 2020 937
16 Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection Li Liu, Qiang Wei, Qingqing Lin et al. · JCI Insight Open access 20 Feb 2019 919
17 Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses Furong Qi, Qian Shen, Shuye Zhang et al. · Biochemical and Biophysical Research Communications Open access 18 Mar 2020 913
18 Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains Yuan Yuan, Duanfang Cao, Yanfang Zhang et al. · Nature Communications Open access 10 Apr 2017 849
19 Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020 Jiaye Liu, Xuejiao Liao, Shen Qian et al. · Emerging infectious diseases Open access 3 Mar 2020 831
20 Two Methods for Mapping and Visualizing Associated Data on Phylogeny Using Ggtree Guangchuang Yu, Tommy Tsan‐Yuk Lam, Huachen Zhu et al. · Molecular Biology and Evolution Open access 18 Oct 2018 799
21 Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes Jie Li, Daniel Q. Huang, Biyao Zou et al. · Journal of Medical Virology ReviewOpen access 13 Aug 2020 772
22 Treeio: An R Package for Phylogenetic Tree Input and Output with Richly Annotated and Associated Data Ligen Wang, Tommy Tsan‐Yuk Lam, Shuangbin Xu et al. · Molecular Biology and Evolution Open access 18 Oct 2019 751
23 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis Michael Huan Le et al. · Clinical Gastroenterology and Hepatology Review 7 Dec 2021 722
24 Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Ruchong Chen et al. · CHEST Journal Open access 15 Apr 2020 694
25 Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 Yang Yang et al. · Journal of Allergy and Clinical Immunology Open access 29 Apr 2020 693
26 Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections Yang Yang et al. · medRxiv PreprintOpen access 12 Feb 2020 692
27 Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension Juan Meng, Guohui Xiao, Juanjuan Zhang et al. · Emerging Microbes & Infections Open access 2020 650
28 Incidence and Etiology of Drug-Induced Liver Injury in Mainland China Tao Shen et al. · Gastroenterology Open access 10 Feb 2019 629
29 First case of COVID-19 complicated with fulminant myocarditis: a case report and insights Jia-Hui Zeng, Ying-Xia Liu, Jing Yuan et al. · Infection Open access 10 Apr 2020 591
30 Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility Jiao Zhao, Yan Yang, Han-Ping Huang et al. · Clinical Infectious Diseases Open access 3 Aug 2020 578
31 Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients With Coronavirus Disease 2019 Zijie Shen, Yan Xiao, Lu Kang et al. · Clinical Infectious Diseases Open access 25 Feb 2020 577
32 Etiological and epidemiological features of acute respiratory infections in China Zhongjie Li et al. · Nature Communications Open access124 authors 18 Aug 2021 563
33 Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression Sujun Chen et al. · Nature Cell Biology 2021 561
34 Global liver disease burdens and research trends: Analysis from a Chinese perspective Jia Xiao, Fei Wang, Nai-Kei Wong et al. · Journal of Hepatology 11 Mar 2019 559
35 Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19) Kaijin Xu et al. · Clinical Infectious Diseases Open access Apr 2020 556
36 Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients Pierre Bost, Amir Giladi, Yang Liu et al. · Cell Open access 8 May 2020 526
37 Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody Lianpan Dai, Jian Guo Song, Xishan Lu et al. · Cell Host & Microbe Open access May 2016 517
38 Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study Kun Wang, Xue Lu, Hui Zhou et al. · Gut Open access 5 May 2018 514
39 Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 Juanjuan Zhao et al. · medRxiv PreprintOpen access 3 Mar 2020 510
40 COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China Qingxian Cai, Deliang Huang, Pengcheng Ou et al. · Allergy Open access 2 Apr 2020 499
41 The genesis and source of the H7N9 influenza viruses causing human infections in China Tommy Tsan‐Yuk Lam et al. · Nature Open access 20 Aug 2013 481
42 Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia Jamal S. M. Sabir et al. · Science 18 Dec 2015 474
43 Relationship between the ABO Blood Group and the COVID-19 Susceptibility Jiao Zhao, Yan Yang, Han-Ping Huang et al. · medRxiv PreprintOpen access 16 Mar 2020 455
44 T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV William J. Liu, Min Jie Zhao, Kefang Liu et al. · Antiviral Research Open access 11 Nov 2016 436
45 Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China Ruchong Chen et al. · Journal of Allergy and Clinical Immunology Open access 11 May 2020 417
46 TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression Xin Gao, Yibei Zhu, Gang Li et al. · PLoS ONE Open access 17 Feb 2012 408
47 MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease Gary Wong, Wenjun Liu, Yingxia Liu et al. · Cell Host & Microbe Open access Oct 2015 396
48 Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma Jian Huang, Qing Deng, Qun Wang et al. · Nature Genetics 26 Aug 2012 395
49 Potent human neutralizing antibodies elicited by SARS-CoV-2 infection Bin Ju et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 25 Mar 2020 388
50 Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease Lu Chen, Meizhou Liu, Zheng Zhang et al. · British Journal of Ophthalmology Open access 7 Apr 2020 382

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.